MNPR - SEDG GLMD and MNPR among pre market gainers
Hancock Jaffe Laboratories HJLI +40% on Breakthrough Device tag for VenoValve Wilhelmina International (NASDAQ:WHLM) +36%. Outlook Therapeutics OTLK +35% on late-stage wet AMD bevacizumab study results Translate Bio TBIO +29% Sanofi to acquire Translate Bio for $3.2B to boost mRNA technology Hollysys Automation Technologies HOLI +24% surges post-market as board evaluates acquisition offers AutoWeb AUTO +17% on acquiring CarZeus assets for expanding offering beyond current market Processa Pharmaceuticals (NASDAQ:PCSA) +13%. ZoomInfo Technologies ZI +12% on Q2 Earnings Arcturus Therapeutics ARCT +12% gets Singapore regulatory greenlight for STARR mRNA vaccine trials SolarEdge Technologies (NASDAQ:SEDG) +11% Minim, Inc. Common Stock (NASDAQ:MINM) +11%. Galmed Pharmaceuticals (NASDAQ:GLMD) +8%. Ralph Lauren Corporation RL +8%. after going on the offensive with big marketing spend Cassava Sciences SAVA +8% on Q2 earnings Monopar Therapeutics (NASDAQ:MNPR) +7% FDA Clearance to Proceed with Camsirubicin Clinical Trial Targeting Advanced Soft Tissue Sarcoma Perion Network PERI +7% on Q2 earnings International Game IGT +7% on Q2 earningsiFresh (NASDAQ:IFMK) +6%. Under Armour UAA +6% on Q2 earnings Pitney Bowes PBI +5% on Q2 earnings
For further details see:
SEDG, GLMD and MNPR among pre market gainers